Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mitsuyoshi Nakashima
Effects of Vapiprost, a Novel Thromboxane Receptor Antagonist, on Thrombus Formation and Vascular Patency After Thrombolysis by Tissue-Type Plasminogen Activator
British Journal of Pharmacology
Pharmacology
Related publications
Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).
The Japanese Journal of Pharmacology
Role of Thrombin and Thromboxane A2 in Reocclusion Following Coronary Thrombolysis With Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator
Surgery for Cerebral Stroke
Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Novel Actions of Tissue-Type Plasminogen Activator in Chronic Kidney Disease
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.
Journal of Pharmacobio-Dynamics